Didn’t we already get this straight?

The embryonic stem cell debate was practically silenced with the latest advancements in the recovery and success of skin and adult stem cells. The moral and ethical recovery.

Somebody needs to do a better public awareness campaign about this, because it’s still out there.

Supporters of a ballot measure that would loosen Michigan’s restrictions on embryonic stem cell research took a big step toward placing it on the November ballot.

What? Why?

Ballot proposal supporters say changing Michigan’s law would help broaden the type of available stem cell lines, opening up new avenues for potential cures and eventually drawing more research money to the state.

Bingo. There’s a lot of money to be made in this biotech research, and Michigan is trying to get some of what Missouri got when they deceived voters with enough disinformation to pass the ballot initiative in the mid-term election. That attracted very profitable biotech researchers to the state.

We still need clarity on this. Especially with statements like this at the end of the article:

While many scientists say embryonic stem cell research holds the most medical versatility and potential, critics are upset that stem cells are harvested from adults or umbilical cords.

It’s a ‘what’s wrong with this sentence’ exercise for those paying attention.